Pilot study of the bile acid and short-chain fatty acid panels
Ended Awarded Last action
- Contract number
- HHSN26100003
- Awardee
-
Metabolon, Inc. UEI SBY5A7EK9PU3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,000
Award facts
- Opportunity
-
- N02CP7100272 Solicitation number
- Metabolomic Profiling for Molecular Epidemiology Studies Award Notice · Posted Oct 31, 2016
- Contract value 100% obligated
- $12,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27713, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $12,000 |
About this award
This is a firm fixed-price delivery order contract awarded to Metabolon, Inc., a self-certified small disadvantaged business, by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The contract, valued at $12,000.00, is for a pilot study to analyze bile acid and short-chain fatty acid panels. This work supports the NCI's Metabolomic Profiling for Molecular Epidemiology Studies program, which leverages advanced metabolomics techniques to gain insights into disease processes, drug mechanisms, and overall health. As a prime contractor, Metabolon has extensive experience providing specialized metabolomics analysis services to various federal agencies, including the Department of Veterans Affairs, NIH, Food and Drug Administration, Department of Defense, and Environmental Protection Agency. The company holds several indefinite delivery contracts with these agencies, enabling efficient procurement of its proprietary metabolomics capabilities to support a wide range of research initiatives. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to Metabolon, Inc. by National Cancer Institute (National Institutes of Health) on July 18, 2017.
How much is contract HHSN26100003 worth?
The government has obligated $12,000 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a delivery order under HHSN261201700009I, an indefinite delivery contract.
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award